Mejías C, Barboza M, Salgado P, Marrufo O, Delgado RD

Language: Spanish
References: 15
Page: 247-250
PDF size: 157.01 Kb.

ABSTRACT

Parkinsonian syndromes are difficult to differentiate among them. Our main objective was to determine morphometric parameters as well as apparent diffusion coefficient (ADC) data, regarding differentiation between patients confirmed with Parkinsonian syndromes; the following diagnoses were included, Parkinson´s disease (PA), supranuclear progressive palsy (SPP), and multiple system atrophy (MSA), eleven patients were recruited in each group. Paired healthy individuals served as control groups for every diagnosis. For every patient and healthy control, MRI studies where acquired, including T2, SPGR and diffusion sequencing. Statistical analysis as applied using SPSS program. Statistically significant differences were noticed among Parkinsonian syndrome groups regarding morphometric measurments; specifically ponto-- mesencephalic relation, which was significantly less in patients harboring SPP than in those with PD or MSA. ADC values allowed for differentiating patients with diagnosis of PD from MSA, however, our results correlate partially with previous studies and show asymmetry with other results. Hence we conclude that ponto mesencephalic relation can be used as an additional parameter for differentiating among patients with SPP and other parkinsonian syndromes. Our results show that ADC differentiation between parkinsionian syndromes is limited.

REFERENCES

1. Ahlskog Je. Diagnosis and dif ferential diagnosis of parkinson’s disease and parkinsonism. Parkinsonism and Related Disorders 2001; 7: 63 70.

2. Sitburana O. Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Related Dis 2009; 15:165-74.

3. Tsuboi Y. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003;60:1766-9.

4. Morelli M. MRI measurements predict PSP in unclassifiable parkinsonisms. Neurol 2011;77:1042-7.

5. Karimi M. MRI measures predict progressive supranuclear palsy. Neurol 2011; 77:1028-9.

6. Oba H. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurol 2005;64:2050-5.

7. Paviour Dc. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005;64:675-9.

8. Righini A. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and parkinson disease. AJNR 2004; 25:927-32.

9. Quattrone A. MR imaging index for dif ferentiation of progressive supranuclear palsy from parkinson disease and the parkinson variant of multiple system atrophy. Radiol 2008; 246: 214-21.

10. Massey l. The midbrain to pons ratio a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013; 80: 1856-61.

11. Ahualli J. Aspectos generales de las secuencias de difusión de imagen en resonancia magnética. Rev Arg Radiol 2010; Vol. 74:3.

12. Nicoletti G. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the parkinson variant of msa from parkinson’s disease and progressive supranuclear palsy. Brain 2006; 129: 2679-87.

13. Schocke M. Dif fusion weighted MRI differentiates the parkinson variant of multiple system atrophy from PD. Neurology 2002;58:575-80.

14. Seppi K. Diffusion weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003; 60(6):922-7.

15. Rizzo G. Diffusion weighted brain imaging study of patients with clinical diagnosis of cor ticobasal degeneration, progressive supranuclear palsy and parkinson’s disease. Brain 2008; 131: 2690-700.